A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

The pharmaceutical company AstraZeneca has filed a federal lawsuit against Utah Attorney General Derek Brown and Utah ...

EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...

Only 25% of AI projects meet ROI goals. IBM argues the solution is strategy-first, not more hype. Learn how to scale AI with ...

President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...

More than 240,000 people have signed a petition to ban dog testing ...

In the week ending June 6, 2025, the Indian equity markets posted significant gains, bolstered by a surprise 50 basis points ...

With a focus on leveraging digital tools to build scalable platforms, the company supports projects that combine innovation, sustainability, and mass-market utility.